Table 1.
Baseline variables | HT(+) (46) | HT(–) (283) | p-value |
---|---|---|---|
Age (mean) [SD] | 71.9 [11.17] | 70.7 [13.2] | 0.527 |
Ethnicity | |||
African (%) | 0 (0%) | 1 (0.35%) | |
Hispanic (%) | 35 (76.1%) | 206 (72.8%) | |
White (%) | 11 (23.9%) | 74 (26.1%) | |
Other (%) | 0 (0%) | 2 (0.71%) | 0.889 |
Sex | |||
Male (%) | 23 (50.0%) | 149 (52.7%) | |
Female (%) | 23 (50.0%) | 134 (47.3%) | 0.7529 |
NIHSS score upon admission (median) [range] | 20.59 [6.25] | 16.05 [7.97] | 0.00027 |
Morbidities | |||
Hypertension (%) | 41 (89.1%) | 250 (88.3%) | 0.99 |
CHF (%) | 2 (4.3%) | 32 (11.3%) | 0.195 |
CAD (%) | 13 (28.3%) | 88 (31.1%) | 0.8633 |
Hyperlipidemia (%) | 24 (52.2%) | 163 (57.6%) | 0.5233 |
Currently smoking (%) | 2 (4.3%) | 29 (10.2%) | 0.2804 |
Diabetes mellitus (%) | 27 (58.7%) | 121 (42.8%) | 0.0548 |
History of stroke/TIA (%) | 10 (21.7%) | 63 (22.3%) | 0.99 |
Pre-treatment IV tPA (%) | 22 (47.8%) | 113 (39.8%) | 0.334 |
Pre-procedure mTICI score | |||
0 (%) | 41 (89.10%) | 239 (83.0%) | |
1 (%) | 2 (4.35%) | 26 (9.19%) | |
2a (%) | 3 (6.52%) | 18 (6.0%) | 0.551 |
Occlusion location | |||
MCA | 29 (63.04%) | 192 (67.77%) | |
Carotid | 13 (30.43%) | 66 (23.30%) | |
M2 | 2 (4.35%) | 9 (3.18%) | |
PCA, VA, ACA | 2 (4.35%) | 16 (5.65%) | 0.844 |
Tandem occlusion | 8 (17.4%) | 79 (27.9%) | 0.133 |
Procedural variables | |||
Number of passes per procedure | |||
1 | 21 (45.7%) | 156 (55.1%) | |
2 | 20 (43.5%) | 84 (29.7%) | |
3 | 5 (10.9%) | 31 (11.0%) | |
4 | 0 (0%) | 9 (3.2%) | |
5 | 0 (0%) | 2 (0.71%) | 0.201 |
Time from: | |||
Onset to arrival (hours) [SD] | 4.02 [4.21] | 4.39 [4.00] | 0.626 |
ED arrival to recanalization (minutes) [SD] | 53.50 [15.37] | 58.68 [29.4] | 0.245 |
Groin puncture to recanalization (minutes) [SD] | 37.13 [15.47] | 41.57 [28.1] | 0.297 |
Stent-retriever sizing* | |||
3x, 4x (%) | 20 (50%) | 123 (48.8%) | |
6x (%) | 20 (50%) | 129 (51.2%) | 0.889 |
Catheter type | |||
Guide catheter (%) | 46 (100%) | 275 (97.2%) | |
Balloon catheter (%) | 0 (0%) | 8 (3.2%) | 0.606 |
Size 5x not included in analysis.